ResearcherSoochow UniversityNo recent work listed

Xin Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1078-7332; OpenAlex author ID A5088004444. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper

Papers 1

Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo. Last author DOI 10.21037/tcr-20-2627 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dechun Li · 1 shared paper, 2021 · strength 0.15
- Paper Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo. DOI 10.21037/tcr-20-2627 ↗
Dongming Zhu · 1 shared paper, 2021 · strength 0.15
- Paper Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo. DOI 10.21037/tcr-20-2627 ↗
Dongbao Li · 1 shared paper, 2021 · strength 0.15
- Paper Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo. DOI 10.21037/tcr-20-2627 ↗
Tao Chen · 1 shared paper, 2021 · strength 0.15
- Paper Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo. DOI 10.21037/tcr-20-2627 ↗
Zixiang Zhang · 1 shared paper, 2021 · strength 0.15
- Paper Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo. DOI 10.21037/tcr-20-2627 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.